Xalatan 0.005%
In brief
- In our pharmacy, you can buy Xalatan 0.005% with a prescription, with delivery throughout the United Kingdom. Discreet and anonymous packaging.
- Xalatan 0.005% treats open-angle glaucoma and ocular hypertension by reducing intraocular pressure through increased aqueous humour outflow as a prostaglandin analogue.
- The usual dosage is one drop of 0.005% solution in the affected eye(s) once daily, preferably in the evening.
- Form of administration is ophthalmic solution (eye drops) applied topically.
- The onset of action begins within 3-4 hours after administration.
- Duration of action lasts approximately 24 hours per dose.
- No known interaction with alcohol; consumption is acceptable per standard medical guidance.
- Most common side effects include iris pigmentation changes, eyelash growth, periocular skin darkening, and eye redness.
- Would you like to try Xalatan 0.005% with a prescription?
Basic Xalatan 0.005% information
| International name | Latanoprost |
|---|---|
| Common brands | Xalatan, Monoprost |
| Classification | ATC Code: S01EE01 |
| Formulation | Ophthalmic solution 0.005% |
| Suppliers | Viatris (Xalatan); Laboratoires Théa (Monoprost) |
| Regulatory status | Prescription-only medicine (POM) |
| Packaging | 2.5 ml dropper bottles |
Xalatan 0.005% contains latanoprost, a medication developed to manage ocular pressure in glaucoma patients. Available as eye drops, this prescription-only solution comes in dropper bottles containing 2.5 ml of medication. Xalatan is made by Viatris (formerly Pfizer) and is dispensed by UK pharmacies on prescription. Preservative-free alternatives such as Monoprost® may be considered for patients experiencing sensitivity reactions.
UK patients may encounter different brand variations including Monoprost, but all contain the same active ingredient concentration. Proper storage requires refrigeration before opening, with careful adherence to expiry timelines post-opening. As a prescription medication, Xalatan requires regular ophthalmology reviews within NHS treatment pathways.
How Xalatan lowers eye pressure: a simple explanation
Xalatan drops reduce intraocular pressure by mimicking natural prostaglandins when applied to the eye surface. They specifically activate FP prostaglandin receptors along the eye’s drainage pathways. This action increases fluid outflow through uveoscleral routes – secondary drainage channels that bypass conventional pathways.
After administration, Xalatan begins lowering pressure within approximately 3 hours of use. Maximum effectiveness occurs between 8-12 hours post-application, making evening dosing clinically advantageous due to natural pressure fluctuations throughout the day.
Unique aspects include:
- Substantial pressure reduction, typically around 25–30% from baseline
- Pro-drug activation primarily occurs through corneal metabolism
- Specialised evening dosing schedule maintains consistent 24-hour control
- Most patients experience peak absorption around two hours post-application
The medication’s mechanism makes it suitable for long-term management. Regular pressure monitoring is needed to confirm the therapeutic response.
Conditions treated by Xalatan: official and investigational uses
In the UK, the licensed indications for Xalatan centre on ocular pressure management. Specifically:
Primary approved conditions:
Important usage restrictions:
Dosing guidelines: when and how to use Xalatan drops
Following UK prescribing protocols ensures optimum pressure control while minimising adverse reactions. Recommended Xalatan dosing involves:
| Patient group | Standard protocol | Special considerations |
|---|---|---|
| Adults | One drop nightly per affected eye | Wait at least 5 minutes between different eye drops |
| Elderly | No dosage adjustment needed | Check manual dexterity issues |
| Children | One drop nightly per affected eye | Under specialist supervision |
| Renal/hepatic impairment | Standard dosing | No adjustment usually needed |
If you forget your dose, administer upon recall unless nearing next scheduled dose. Never double-dose. Do not stop treatment without advice from your eye specialist, as eye pressure can rise again.
Consistent evening application optimises results. When using:
- Administer before bedtime
- Wait at least 5 minutes between different eye medications
- Store open bottles at room temperature
- Discard bottles 4 weeks after opening
Xalatan 0.005% administration best practices and storage
Using eye drops correctly maximises Xalatan’s effectiveness while minimising contamination risks. Clean hands are essential before touching the vial. Tilt your head back slightly and gently pull down the lower eyelid to form a pouch. Position the dropper above without touching the eye surface. Apply one drop, avoiding eyelid or lashes. Close eyes for one minute without squeezing.
Storage is equally vital. Unopened vials require refrigeration between 2°C-8°C away from light. Once opened, keep containers at room temperature under 25°C – home medicine cabinets often exceed this. Discard any remaining solution four weeks after opening, regardless of the expiry date.
Never freeze contents or transfer solutions to other containers.
Xalatan 0.005% contraindications and risk factors
Certain conditions make Xalatan potentially harmful for some individuals. Immediate contraindications include known allergies to latanoprost or any ingredient in the formulation. Those with active herpes simplex keratitis should avoid treatment completely – viral infections can worsen dramatically.
High-risk groups needing extra monitoring include patients with only one functional eye (monophthalmos) due to higher consequence from complications. Severe asthma sufferers should use cautiously following rare reports of bronchospasm. Post-surgery patients face specific hazards: pseudophakic individuals with posterior lens capsule tears have increased macular oedema risk.
Uveitis can be exacerbated in patients with a history of intraocular inflammation, which requires prompt ophthalmologist review.
Xalatan 0.005% adverse reactions: common to severe
| Frequency | Side effects | Management |
|---|---|---|
| Very common (more than 1 in 10) | Permanent iris colour darkening (mixed-colour irises most affected), longer/thicker eyelashes, periocular skin darkening. Typically cosmetic changes developing over months. | Counsel about permanent nature before starting treatment. Consider lubricants for dry eye. |
| Very common / common | Burning/stinging sensations immediately after instillation, conjunctival redness. | Apply drops at bedtime & refrigerate unopened vials to reduce irritation. Peak discomfort resolves within 5 minutes. |
| Uncommon / rare | Uveitis symptoms (blurred vision, eye pain), cystoid macular oedema presenting as distorted central vision. | Urgent referral since risk escalates in aphakic patients or those with anterior chamber lenses. |
Iris pigmentation changes develop gradually and are likely to be permanent, unlike eyelash changes.
Xalatan 0.005% therapeutic alternatives comparison
| Drug | Pros | Cons |
|---|---|---|
| Xalatan | Over 20 years of clinical use | Iris colour change in some long-term users |
| Monoprost® | Preservative-free formula, reduced irritation | Same side-effect profile as latanoprost |
| Bimatoprost (Lumigan) | Marginally stronger IOP reduction | Higher hyperaemia risk |
Other alternatives include travoprost (Travatan) and tafluprost (Saflutan). Preservative-free options are available for patients with sensitivity to benzalkonium chloride.
Xalatan 0.005% frequently asked patient questions
Can I use Xalatan while breastfeeding?
Is driving after using these drops safe?
How to reduce stinging sensation?
Xalatan 0.005% guidelines for proper use
Timing matters
Storage precautions
Administration tips
- Press tear duct corner for 60 seconds post-application
- Avoid makeup for 10 minutes after instilling
- Always replace the cap immediately after use
Discard bottles 4 weeks after opening.
